PELL Bio-Med Technology Co (TPE:6949) FCF Margin %: -2,555.36% (As of Dec. 2025)


TPE:6949 PELL Bio-Med Technology Co Ltd TPE:6949
13 GF Score
Price NT$862.00
! 5 Warning Signs
View Full Analysis

What is PELL Bio-Med Technology Co FCF Margin %?

PELL Bio-Med Technology Co TPE:6949 -1.93% 13 FCF Margin % is -2,555.36% as of Dec. 2025. GuruFocus rates TPE:6949 with a GF Score™ of 13/100. The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, PELL Bio-Med Technology Co ranks worse than 83.21% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PELL Bio-Med Technology Co's Free Cash Flow for the three months ended in Dec. 2025 was NT$-155.09 Mil. PELL Bio-Med Technology Co's Revenue for the three months ended in Dec. 2025 was NT$6.07 Mil. Therefore, PELL Bio-Med Technology Co's FCF Margin % for the quarter that ended in Dec. 2025 was -2,555.36%.

As of today, PELL Bio-Med Technology Co's current FCF Yield % is -0.88%.

The historical rank and industry rank for PELL Bio-Med Technology Co's FCF Margin % or its related term are showing as below:

TPE:6949' s FCF Margin % Range Over the Past 10 Years
Min: -2669.76   Med: -1089.53   Max: -875.12
Current: -1619.44


During the past 5 years, the highest FCF Margin % of PELL Bio-Med Technology Co was -875.12%. The lowest was -2669.76%. And the median was -1089.53%.

TPE:6949's FCF Margin % is ranked worse than
83.21% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs TPE:6949: -1619.44


PELL Bio-Med Technology Co FCF Margin % Related Terms


PELL Bio-Med Technology Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for PELL Bio-Med Technology Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PELL Bio-Med Technology Co FCF Margin % Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
-875.12 -987.80 -1,089.53 -2,669.76 -1,619.44

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,708.06 -924.17 -1,533.71 -2,034.16 -2,555.36

TPE:6949 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, PELL Bio-Med Technology Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PELL Bio-Med Technology Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PELL Bio-Med Technology Co's FCF Margin % falls into.


TPE:6949
13GF Score
PELL Bio-Med Technology Co Ltd TPE:6949
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PELL Bio-Med Technology Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PELL Bio-Med Technology Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-508.893/31.424
=-1,619.44 %

PELL Bio-Med Technology Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-155.085/6.069
=-2,555.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -2,555.36% mean?
PELL Bio-Med Technology Co (TPE:6949) has a FCF Margin % of -2,555.36% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PELL Bio-Med Technology Co and its competitors. According to the industry distribution chart, PELL Bio-Med Technology Co ranks #798 out of 959 companies in the Biotechnology industry, placing it in the top 83.2%.
Is PELL Bio-Med Technology Co's FCF Margin % too high?
PELL Bio-Med Technology Co's current FCF Margin % is -2,555.36%. Based on the distribution chart, PELL Bio-Med Technology Co ranks #798 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PELL Bio-Med Technology Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PELL Bio-Med Technology Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PELL Bio-Med Technology Co ranks #798 out of 959 companies for FCF Margin %. This places PELL Bio-Med Technology Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PELL Bio-Med Technology Co and its competitors. PELL Bio-Med Technology Co's current FCF Margin % is -2,555.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PELL Bio-Med Technology Co stock overvalued right now?
PELL Bio-Med Technology Co (TPE:6949) has a current FCF Margin % of -2,555.36%. The current FCF Margin % is -2,555.36%. PELL Bio-Med Technology Co's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For PELL Bio-Med Technology Co (TPE:6949), the current FCF Margin % is -2,555.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PELL Bio-Med Technology Co Business Description

Address No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score

Get the complete analysis for TPE:6949

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$862.00
Price